Adient (NYSE:ADNT – Free Report) had its target price hoisted by UBS Group from $15.00 to $25.00 in a report released on Monday morning,Benzinga reports. The firm currently has a neutral rating on the stock.
A number of other analysts also recently issued reports on the company. Bank of America raised their target price on Adient from $15.00 to $17.50 and gave the stock an “underperform” rating in a research note on Monday, June 16th. Citigroup assumed coverage on Adient in a research report on Wednesday, April 23rd. They set a “neutral” rating and a $14.00 price objective for the company. Morgan Stanley cut their price objective on Adient from $17.00 to $16.00 and set an “underweight” rating for the company in a research report on Monday, May 19th. Barclays downgraded Adient from an “equal weight” rating to a “negative” rating in a research report on Tuesday, April 15th. Finally, Wells Fargo & Company raised their price objective on Adient from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 1st. Three analysts have rated the stock with a sell rating and seven have given a hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $18.56.
Get Our Latest Stock Report on ADNT
Adient Price Performance
Adient (NYSE:ADNT – Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.33. The firm had revenue of $3.61 billion for the quarter, compared to analyst estimates of $3.39 billion. Adient had a positive return on equity of 7.70% and a negative net margin of 1.86%. The business’s revenue was down 3.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.54 EPS. On average, sell-side analysts forecast that Adient will post 1.76 EPS for the current year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of ADNT. Point72 Hong Kong Ltd purchased a new stake in Adient during the fourth quarter worth $25,000. Brooklyn Investment Group boosted its position in Adient by 23,600.0% during the first quarter. Brooklyn Investment Group now owns 2,133 shares of the company’s stock worth $27,000 after purchasing an additional 2,124 shares in the last quarter. GAMMA Investing LLC boosted its position in Adient by 157.5% during the first quarter. GAMMA Investing LLC now owns 2,235 shares of the company’s stock worth $29,000 after purchasing an additional 1,367 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its position in Adient by 991.0% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 2,182 shares of the company’s stock worth $42,000 after purchasing an additional 1,982 shares in the last quarter. Finally, CWM LLC boosted its position in Adient by 91.4% during the first quarter. CWM LLC now owns 3,426 shares of the company’s stock worth $44,000 after purchasing an additional 1,636 shares in the last quarter. Institutional investors and hedge funds own 92.44% of the company’s stock.
Adient Company Profile
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Recommended Stories
- Five stocks we like better than Adient
- 3 Best Fintech Stocks for a Portfolio Boost
- These 3 Undervalued Stocks Could Surge as Value Rotation Nears
- Earnings Per Share Calculator: How to Calculate EPS
- Tilray Shares Blazing: What’s Behind the 55% Rally This Month?
- The Significance of Brokerage Rankings in Stock Selection
- 3 Retail Stocks to Watch as Back-to-School Spending Ramps Up
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.